Non-opioid Pain Focus Target institutions and payers seeking non-opioid pain management solutions, particularly in postsurgical pain, where vocacapsaicin is positioned as a first-in-class therapy.

Clinical-stage Partnerships Leverage ongoing and past collaborations with academic and medical centers such as URMC to pursue co-development, research alliances, and joint clinical studies that can expand adoption and access.

Clinical Data Momentum Highlight favorable clinical data and poster presentations from major pain and anesthesia conferences to support value propositions for surgeons, pain specialists, and procurement teams.

Strategic Funding Signals Acknowledge a history of substantial funding rounds and convertible notes, signaling investor confidence; use as leverage to discuss long-term partnerships, milestones, and potential co-funding opportunities.

Early Commercial Readiness Position for early engagement with specialty distributors and hospital formularies, given private, clinical-stage status and focused niche in acute and chronic pain management.